FindTrial
Sign In

Studying how blood clotting changes in healthy pregnant women by testing blood samples taken at different stages of pregnancy.

Establishing the Normal Reference Ranges of Thromboelastogram(TEG) Parameters in Healthy Pregnant Women at a Tertiary Care Hospital in Coastal Karnataka. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112979
Enrollment
96
Registered
2026-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O991- Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Nil: Nil

Sponsors

Transfusion Medicine Academic Society
Lead Sponsor
Kasturba Medical College
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Healthy pregnant women

Exclusion criteria

Exclusion criteria: High risk pregnancy / known history of bleeding disorders / history of thrombotic disorders / family history of coagulation disorders / history of APLA,SLE or any other autoimmune conditions / hypertension / Preeclampsia / family history of coagulopathy.

Design outcomes

Primary

MeasureTime frame
The Reference ranges established would be further used in our laboratory for all pregnant women for better management of coagulopathy.Timepoint: The Reference ranges established would be assessed at 12 weeks,24weeks and 36weeks.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDrGanesh Mohan

Kasturba Medical College, Manipal

drganeshmohan@gmail.com9539788828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026